Regulatory Press Releases
PILA PHARMA PUBLISHES YEAR-END REPORT (1 January – 31 December 2023)
Malmö, 28 February, 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s year-end report for the period January - December 2023. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF YEAR-END REPORT Fourth quarter (1 October - 31 December 2023) Revenue was 366 kSEK (413) Operating loss (EBIT)…
Pila Pharma AB announces outcome in the rights issue
Malmö, 5 December 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…
PILA PHARMA ANNOUNCES PRECLINICAL RESEARCH COLLABORATION
Malmö, 26 November 2023 Download the press release as PDF here Pila Pharma AB (publ) ("Pila Pharma" or the "Company") has entered a research collaboration with the Research Group of Professor Dick Wågsäter, Uppsala University, Sweden (the "Research Group") on investigating the effect of XEN-D0501 on Abdominal Aorta Aneurism growth in mice. The hypothesis is that XEN-D0501 may reduce the chronic…
PILA PHARMA PUBLISHES INTERIM REPORT (1 July – 30 September 2023)
Malmö, 25 October, 2023 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period July – September 2023. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/. SUMMARY OF INTERIM REPORT THIRD QUARTER (1 JULY – 30 SEPTEMBER 2023) Operating income amounted to TSEK 0 (281) The…
PILA PHARMA’S BOARD OF DIRECTORS HAS RESOLVED TO CARRY OUT A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 26.2 MILLION
Malmö, 25 October, 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…